‘X4 Pharmaceuticals gets FDA Orphan Drug Designation for Mavorixafor for treatment of Waldenstrom’s Macroglobulinemia’ -TradeHawk, Citing FDA Site
https://twitter.com/TradeHawk/status/1542897334085775360
GM Says Sales To Commercial, Government And Rental Fleets Grew 29% YoY; Says Saw ‘Significant pent-up demand for GM vehicles amid low inventories’
https://investor.gm.com/news-releases/news-release-details/gm-continued-gain-us-market-share-and-extended-its-truck
GM Releases PR On Business Update
https://investor.gm.com/news-releases/news-release-details/gm-continued-gain-us-market-share-and-extended-its-truck
AstraZeneca Shares Data At EASL And ESMO World GI For IMFINZI Combinations In Patients With Liver And Biliary Tract Cancers
survival vs. sorafenib in patients with unresectable liver cancer regardless of baseline liver functional reserve
TOPAZ-1 Phase III trial subgroup analysis showed the addition of IMFINZI to standard-of-care chemotherapy
Medigus Announces Eventer Signs Agreements With Two Teams From The Israeli Basketball Premier League And The Israeli National Basketball League
Eventer will leverage its capabilities in the sports sector and intends to expand its outreach to leagues in the US and Europe
Tel Aviv, Israel, July 01, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS)